Real-Time Imaging of Brain Tumor for Image-Guided Surgery

被引:95
作者
Hu, Shuang [1 ,2 ,3 ]
Kang, Homan [2 ,3 ]
Baek, Yoonji [2 ,3 ]
El Fakhri, Georges [2 ,3 ]
Kuang, Anren [1 ]
Choi, Hak Soo [2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu 610041, Sichuan, Peoples R China
[2] Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02114 USA
关键词
brain tumors; contrast agents; image-guided therapy; intraoperative imaging; real-time imaging; NEAR-INFRARED FLUOROPHORES; GRADE GLIOMA RESECTION; FLUORESCEIN SODIUM; SURGICAL RESECTION; MALIGNANT GLIOMAS; QUANTUM DOTS; ALPHA(V)BETA(3)-INTEGRIN EXPRESSION; ENHANCED PERMEABILITY; 5-AMINOLEVULINIC ACID; CLINICAL TRANSLATION;
D O I
10.1002/adhm.201800066
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The completion of surgical resection is a key prognostic factor in brain tumor treatment. This requires surgeons to identify residual tumors in theater as well as to margin the proximity of the tumor to adjacent normal tissue. Subjective assessments, such as texture palpation or visual tissue differences, are commonly used by oncology surgeons during resection to differentiate cancer lesions from normal tissue, which can potentially result in either an incomplete tumor resection, or accidental removal of normal tissue. Moreover, malignant brain tumors are even more difficult to distinguish from normal brain tissue, and resecting noncancerous tissue may create neurological defects after surgery. To optimize the resection margin in brain tumors, a variety of intraoperative guidance techniques are developed, such as neuronavigation, magnetic resonance imaging, ultrasound, Raman spectroscopy, and optical fluorescence imaging. When combined with appropriate contrast agents, optical fluorescence imaging can provide the neurosurgeon real-time image guidance to improve resection completeness and to decrease surgical complications.
引用
收藏
页数:15
相关论文
共 116 条
[1]   Is fluorescein-guided technique able to help in resection of high-grade gliomas? [J].
Acerbi, Francesco ;
Broggi, Morgan ;
Eoli, Marica ;
Anghileri, Elena ;
Cavallo, Claudio ;
Boffano, Carlo ;
Cordella, Roberto ;
Cuppini, Lucia ;
Pollo, Bianca ;
Schiariti, Marco ;
Visintini, Sergio ;
Orsi, Chiara ;
La Corte, Emanuele ;
Broggi, Giovanni ;
Ferroli, Paolo .
NEUROSURGICAL FOCUS, 2014, 36 (02)
[2]   Therapeutic cancer targeting peptides [J].
Aina, OH ;
Sroka, TC ;
Chen, ML ;
Lam, KS .
BIOPOLYMERS, 2002, 66 (03) :184-199
[3]   Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted Therapy [J].
Akcan, Muharrem ;
Stroud, Mark R. ;
Hansen, Stacey J. ;
Clark, Richard J. ;
Daly, Norelle L. ;
Craik, David J. ;
Olson, James M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (03) :782-787
[4]   RETRACTED: Origin of the U87MG glioma cell line: Good news and bad news (Retracted article. See vol. 19, 2024) [J].
Allen, Marie ;
Bjerke, Mia ;
Edlund, Hanna ;
Nelander, Sven ;
Westermark, Bengt .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (354)
[5]  
Antaris AL, 2016, NAT MATER, V15, P235, DOI [10.1038/nmat4476, 10.1038/NMAT4476]
[6]   Image guided surgery for the resection of brain tumours [J].
Barone, Damiano Giuseppe ;
Lawrie, Theresa A. ;
Hart, Michael G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01)
[7]   αvβ3 and αvβ5 integrin expression in glioma periphery [J].
Bello, L ;
Francolini, M ;
Marthyn, P ;
Zhang, JP ;
Carroll, RS ;
Nikas, DC ;
Strasser, JF ;
Villani, R ;
Cheresh, DA ;
Black, PM .
NEUROSURGERY, 2001, 49 (02) :380-389
[8]   Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology [J].
Bertrand, Nicolas ;
Wu, Jun ;
Xu, Xiaoyang ;
Kamaly, Nazila ;
Farokhzad, Omid C. .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 66 :2-25
[9]   Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications [J].
Black, PM ;
Moriarty, T ;
Alexander, E ;
Stieg, P ;
Woodard, EJ ;
Gleason, PL ;
Martin, CH ;
Kikinis, R ;
Schwartz, RB ;
Jolesz, FA .
NEUROSURGERY, 1997, 41 (04) :831-842
[10]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748